Severe (severity modifier) – Page 2

Almirall’s Ebglyss Gains NICE Recommendation for Atopic Dermatitis Treatment

1 year ago talkbio0Tagged Biological Response Modifier Therapy, Dermatitis, Atopic, Ebglyss, England, lebrikizumab, Moderate (severity modifier), Nance-Horan syndrome, Nitroglycerin/Sodium Citrate/Ethanol Solution, Recommendation, Severe (severity modifier)

Ebglyss, lebrikizumab, atopic dermatitis, NICE recommendation, Almirall, NHS England, biological therapy, moderate to severe atopic dermatitis

Vertex Announces Positive Results for VX-880 in Type 1 Diabetes Treatment

1 year ago talkbio0Tagged Allogeneic Human Stem Cell-derived Pancreatic Islet Cells VX-880, Diabetes, Hypoglycemic Events, Independence, Insulin, Severe (severity modifier), Stem Cell Therapy

Vertex Pharmaceuticals, VX-880, Type 1 Diabetes, Stem Cell Therapy, Insulin Independence, Severe Hypoglycemic Events

FDA Grants Emergency Authorization for Invivyd’s Pemgarda Antibody Prophylactic Against COVID-19 in Immunocompromised Individuals

2 years ago talkbio0Tagged Adolescent (age group), Adults/, Approved, Condoms, Male, COVID19 (disease), Emergency Use Authorization, Half-Life Extended Monoclonal Antibody, immune compromise, Immunocompromised Host, Invivyd, Moderate (severity modifier), Pemgarda, pemivibart, Pre-Exposure Prophylaxis, Prophylactic treatment, Severe (severity modifier), United States Food and Drug Administration, VYD222

Invivyd, Pemgarda (pemivibart; formerly VYD222), Half-Life Extended Monoclonal Antibody, COVID-19 Prophylactic, Immunocompromised Patients, Emergency Use Authorization (EUA), FDA Approval, Moderate to Severe Immune Compromise, Pre-exposure Prophylaxis (Prevention) of COVID-19 in Adults/ Adolescents

FDA Approves Xolair (Omalizumab) for Reducing Severe Outcomes from Multiple Food Allergies

2 years ago talkbio0Tagged Food, Hypersensitivity, omalizumab, Reduced, Severe (severity modifier), United States Food and Drug Administration, Xolair

Xolair, United States Food and Drug Administration, omalizumab, Hypersensitivity, Food, Reduced, Severe (severity modifier)